Recent Updates
Recently added Catalysts
RDGT Positive Sentiment Score: 60/100

China Jo-Jo Drugstores Granted A Second Extension to Meet Nasdaq Minimum Bid Price Requirement

Key Takeaway: China Jo-Jo Drugstores has been granted a 180-day extension by Nasdaq to meet the minimum bid price requirement, which is essential for its continued listing. The new deadline for compliance is June 10, 2024. The company plans to address the deficiency through potential actions such as a reverse stock split. This extension offers the opportunity for the company to stabilize its share price and avoid delisting.

Market Sentiment Analysis

POSITIVE FACTORS

  • China Jo-Jo has received a 180-day extension to meet Nasdaq requirements.
  • The company intends to implement measures such as a reverse stock split to regain compliance.
  • Having until June 10, 2024 provides additional time for recovery.

Full Press Release Details

China Jo-Jo Drugstores Granted A Second Extension
to Meet Nasdaq Minimum Bid Price Requirement
HANGZHOU, China, December 14, 2023 /PRNewswire/
-- China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) (the "Company"), a leading online and offline retailer and wholesale distributor
of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on December 13, 2023, the Company
received another 180 calendar day extension from Nasdaq's Listing Qualifications Department ("Nasdaq") to meet
Nasdaq's continuing listing requirements by maintaining a minimum bid price per share of $1.00 for a minimum of 10 consecutive trading
days (the "Minimum Bid Price Rules"). The Company now has until June 10, 2024 to regain compliance with the Minimum
Such determination is based on the Company meeting
the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on
the Capital Market with the exception of the bid price requirement, and the Company's written notice of its intention to cure the
deficiency during the second compliance period by effecting a reverse stock split, if necessary.
As previously reported, the Company was first
notified by Nasdaq of its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days under Nasdaq Listing
Rules 5550(a)(2) on June 15, 2023, and was given until December 12, 2023 to regain compliance pursuant to Nasdaq Listing Rules 5810(c)(3)(A).
About China Jo-Jo Drugstores, Inc.
China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores"
or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare
products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores
with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale
distributor of products similar to those carried in its pharmacies. For more information about the Company, please visit http://jiuzhou360.com.
The Company routinely posts important information on its website.
Forward-Looking Statements
This press release contains information about
the Company's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ
materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including,
but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow
its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new
products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services,
marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions,
dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary
to meet the requirements of its clients, and its ability to protect its intellectual property. The Company's encourages you to review
other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange
For more information, please contact:
Chief Financial Officer
Investor Relations Contact:
Ascent Investor Relations LLC

Frequently Asked Questions

What extension did China Jo-Jo Drugstores receive from Nasdaq?

The company received a 180-day extension to meet the $1.00 minimum bid price requirement.

When is the new deadline for compliance with Nasdaq?

China Jo-Jo Drugstores must regain compliance by June 10, 2024.

What was the initial compliance deadline set by Nasdaq?

The initial deadline for compliance was December 12, 2023.

What will China Jo-Jo Drugstores do if they can't meet the bid price?

The company may effect a reverse stock split to cure the deficiency if necessary.

What type of products does China Jo-Jo Drugstores offer?

They offer pharmaceutical products and healthcare services both online and offline.

Last updated: Dec 14, 2023